Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 13 records per page: next > | last >>
pages: 1 2 3 4 5 ... 10 11 12 13 presentations: 1 to 25 of 307
Precision Medicine Comes to Cancer Prevention and Screening
Stool DNA detection of colorectal neoplasia: A new high bar for noninvasive screening
David A Ahlquist
Mayo Clinic, Rochester, MN, United States
from AACR Annual Meeting 2015 on April 20, 2015 8:15 AM-10:15 AM
Precision Medicine Comes to Cancer Prevention and Screening
Molecular risk stratification for aspirin chemoprevention
Andrew T. Chan
Massachusetts General Hospital, Boston, MA, United States
from AACR Annual Meeting 2015 on April 20, 2015 8:15 AM-10:15 AM
Precision Medicine Comes to Cancer Prevention and Screening
Early detection and prevention of liver cancer: Leveraging lessons learned from liver repair
Anna Mae E. Diehl
Duke University School of Medicine, Durham, NC, United States
from AACR Annual Meeting 2015 on April 20, 2015 8:15 AM-10:15 AM
Precision Medicine Comes to Cancer Prevention and Screening
Drastically reducing HPV-associated cancers through etiologically-based primary and secondary prevention
Douglas R. Lowy
Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States
from AACR Annual Meeting 2015 on April 20, 2015 8:15 AM-10:15 AM
Clinical Trials of New Drugs in Breast Cancer
A first-in-human phase I study to evaluate the oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with estrogen receptor+ HER2-, advanced/metastatic breast cancer
Maura Dickler
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2015 on April 20, 2015 10:30 AM-12:20 PM
Clinical Trials of New Drugs in Breast Cancer
Discussant
C. Kent Osborne
Baylor College of Medicine Cancer Center, Houston, TX, United States
from AACR Annual Meeting 2015 on April 20, 2015 10:30 AM-12:20 PM
Clinical Trials of New Drugs in Breast Cancer
SU2C Phase Ib study of the PI3K-alpha inhibitor BYL719 (alpelisib) with letrozole in ER+/HER2-metastatic breast cancer
Ingrid A Mayer
Vanderbilt University Medical Center, Nashville, TN, United States
from AACR Annual Meeting 2015 on April 20, 2015 10:30 AM-12:20 PM
Clinical Trials of New Drugs in Breast Cancer
A phase I study evaluating continuous and intermittent AZD2014 in combination with fulvestrant in patients with ER+ advanced metastatic breast cancer
Manish Patel
Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL, United States
from AACR Annual Meeting 2015 on April 20, 2015 10:30 AM-12:20 PM
Clinical Trials of New Drugs in Breast Cancer
Discussant
Matthew J. Ellis
Baylor College of Medicine Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2015 on April 20, 2015 10:30 AM-12:20 PM
Clinical Trials of New Drugs in Breast Cancer
A phase I study of MM-302, a HER2-targeted PEGylated liposomal doxorubicin, in patients with HER2+ metastatic breast cancer
Patricia LoRusso
Yale, New Haven, CT, United States
from AACR Annual Meeting 2015 on April 20, 2015 10:30 AM-12:20 PM
Clinical Trials of New Drugs in Breast Cancer
Discussant
Fabrice Andre
Institut Gustave Roussy, Villejuif, France
from AACR Annual Meeting 2015 on April 20, 2015 10:30 AM-12:20 PM
At the Intersection of Chemistry, Genomics and Biology: Identifying New Targeted Approaches in Leukemia
  •  
  • Permission not
    granted for presentation
  •  
  •  
Invited Speaker
Kimberly Stegmaier
Dana-Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2015 on April 20, 2015 7:00 AM-8:00 AM
Basic Science Insights to Guide PI3K Pathway Targeting in Cancer
  •  
  • Permission not
    granted for presentation
  •  
  •  
Invited Speaker
Bart Vanhaesebroeck
UCL Cancer Institute, London, United Kingdom
from AACR Annual Meeting 2015 on April 20, 2015 7:00 AM-8:00 AM
Bladder Cancer: Functional Genomics leading to Targeted Therapy
  •  
  • Permission not
    granted for presentation
  •  
  •  
Invited Speaker
Dan Theodorescu
University of Colorado Cancer Center, Aurora, CO, United States
from AACR Annual Meeting 2015 on April 20, 2015 7:00 AM-8:00 AM
Head and Neck Cancer: Translational Research Strategies
Invited Speaker
Jennifer Rubin Grandis
University of California, San Francisco, PA, United States
from AACR Annual Meeting 2015 on April 20, 2015 7:00 AM-8:00 AM
Melanoma - Basic Science
  •  
  • Permission not
    granted for presentation
  •  
  •  
Invited Speaker
David E. Fisher
Massachusetts General Hospital, Boston, MA, United States
from AACR Annual Meeting 2015 on April 20, 2015 7:00 AM-8:00 AM
Molecular Pathology in Oncology
Invited Speaker
Massimo Loda
Dana-Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2015 on April 20, 2015 7:00 AM-8:00 AM
Post-GWAS Studies of Epithelial Ovarian Cancer: Now What?
Invited Speaker
Thomas A. Sellers
Moffitt Cancer Center & Research Institute, Tampa, FL, United States
from AACR Annual Meeting 2015 on April 20, 2015 7:00 AM-8:00 AM
Prognostic and Predictive Biomarkers for Anti-HER2 Therapy
Invited Speaker
Edith A. Perez
Mayo Clinic, Ponte Vedra Beach, FL, United States
from AACR Annual Meeting 2015 on April 20, 2015 7:00 AM-8:00 AM
The Cancer Epigenome
Invited Speaker
Peter A. Jones
Van Andel Research Institute, Grand Rapids, MI, United States
from AACR Annual Meeting 2015 on April 20, 2015 7:00 AM-8:00 AM
The NCI PREVENT Cancer Preclinical Drug Development Program
PREVENT Cancer Preclinical Drug Development Program
Robert H. Shoemaker
National Cancer Institute, Bethesda, MD, United States
from AACR Annual Meeting 2015 on April 20, 2015 7:00 AM-8:00 AM
Therapy of Lymphoma Inspired by Functional and Structural Genomics
  •  
  • Permission not
    granted for presentation
  •  
  •  
Invited Speaker
Louis M. Staudt
National Cancer Institute, Bethesda, MD, United States
from AACR Annual Meeting 2015 on April 20, 2015 7:00 AM-8:00 AM
Through the Eyes of a Mouse: The p53 Pathway
Invited Speaker
Guillermina Lozano
UT MD Anderson Cancer Center, Houston, TX, United States
from AACR Annual Meeting 2015 on April 20, 2015 7:00 AM-8:00 AM
Tumor Dormancy and Metastatic Recurrence
Invited Speaker
Ann F. Chambers
London Regional Cancer Program, London, ON, Canada
from AACR Annual Meeting 2015 on April 20, 2015 7:00 AM-8:00 AM
Understanding Cancer: Microenvironment Interactions at Multiple Scales
Invited Speaker
Joe W. Gray
Oregon Health & Science University, Portland, OR, United States
from AACR Annual Meeting 2015 on April 20, 2015 7:00 AM-8:00 AM
<< first | < prev page: of 13 records per page: next > | last >>
pages: 1 2 3 4 5 ... 10 11 12 13 presentations: 1 to 25 of 307